Developing Therapies
To Transform Lives

Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for patients.

Innovative Therapies

Our investigational therapies target rare diseases through three modalities: gene replacement, exon skipping gene therapy and vectorized RNA knockdown. We are leveraging Astellas’ global resources, industry leadership in immune biology, and deep scientific expertise to expand our reach and develop valuable new genetic medicines for patients around the world.

Courageous Patients

We depend on courageous patients and their families to advance our investigational therapies. Our patient communities are important partners and collaborators, informing our clinical trial programs and drug development process.

william
Zak Courageous Patient
emi
Learn More

State-of-the-Art Facilities

The science of genetic medicines is complex. Our robust capabilities and industry leading manufacturing facilities put us at the forefront of developing innovative therapies.

Our People

We take pride in our mission to develop transformative genetic medicines to patients around the world. Our experienced team has the passion and drive to accomplish our goal of helping patients with life-threatening diseases. If you’re looking for a fast-paced work environment where employees whole heartedly embody a “Get Stuff Done” attitude, you’ll fit right in.

MEET OUR TEAM
JOIN OUR TEAM
MEET OUR TEAM
JOIN OUR TEAM
MEET OUR TEAM
JOIN OUR TEAM

@AstellasGeneTx

Learn more about what we’re doing to become the leader in the development and commercialization of innovative genetic medicines, the people who make us who we are, and the exciting job opportunities available by following us on LinkedIn.

Learn more about what we’re doing to become the leader in the development and commercialization of innovative genetic medicines to treat serious rare neuromuscular diseases, the people who make it great and the exciting job opportunities available by following us on LinkedIn.